Rickets and Plasmacytoma

Summary:

Plasmacytoma is found among people with Rickets, especially for people who are male, 60+ old.

The study analyzes which people have Plasmacytoma with Rickets. It is created by eHealthMe based on reports of 12 people who have Rickets from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Rickets?

Rickets (softening of bones) is found to be associated with 1,094 drugs and 1,457 conditions by eHealthMe. Check the latest studies of Rickets.

What is Plasmacytoma?

Plasmacytoma (neoplasm of plasma cells (usually in bone marrow)) is found to be associated with 385 drugs and 240 conditions by eHealthMe. Check the latest studies of Plasmacytoma.



On Jul, 14, 2026

12 people who have Rickets and Plasmacytoma are studied.

Would you have Plasmacytoma when you have Rickets?

Gender of people who have Rickets and experienced Plasmacytoma *:

  • female: 50 %
  • male: 50 %

Age of people who have Rickets and experienced Plasmacytoma *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 11.11 %
  • 50-59: 0.0 %
  • 60+: 88.89 %

Common co-existing conditions for these people *:

  1. Multiple Myeloma (cancer of the plasma cells): 10 people, 83.33%
  2. Bone Pain: 5 people, 41.67%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 33.33%
  4. Urinary Incontinence (inability to control the flow of urine and involuntary urination): 3 people, 25.00%
  5. Pain: 3 people, 25.00%
  6. Nausea (feeling of having an urge to vomit): 3 people, 25.00%
  7. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 25.00%
  8. Constipation: 3 people, 25.00%
  9. Folate Deficiency (lack of folic acid): 3 people, 25.00%
  10. Dry Skin: 3 people, 25.00%

Common drugs taken by these people *:

  1. Revlimid: 6 people, 50.00%
  2. Zometa: 5 people, 41.67%
  3. Pantoprazole: 5 people, 41.67%
  4. Acetaminophen: 5 people, 41.67%
  5. Amitriptyline Hydrochloride: 5 people, 41.67%
  6. Atovaquone: 5 people, 41.67%
  7. Dexamethasone: 5 people, 41.67%
  8. Famotidine: 5 people, 41.67%
  9. Glimepiride: 5 people, 41.67%
  10. Morphine Sulfate: 5 people, 41.67%

Common symptoms for these people *:

  1. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 5 people, 41.67%
  2. Hypocalcaemia (levels of calcium in blood serum are abnormally low): 5 people, 41.67%
  3. Osteolysis (dissolution of bone): 3 people, 25.00%
  4. Chills (felling of cold): 3 people, 25.00%
  5. Constipation: 3 people, 25.00%
  6. Fever: 3 people, 25.00%
  7. General Physical Health Deterioration (weak health status): 3 people, 25.00%
  8. Haematoma Infection (infection with collection of blood outside the blood vessels): 3 people, 25.00%
  9. High Blood Pressure: 3 people, 25.00%
  10. Lymphoedema (localized fluid retention and tissue swelling): 3 people, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Plasmacytoma?

- Check whether Plasmacytoma is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Plasmacytoma:

All the conditions that are associated with Plasmacytoma:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Plasmacytoma and Rickets, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: